Antimicrobial resistance (AMR) poses a significant threat to both human and animal health, demanding innovative solutions to combat infectious diseases effectively. In the realm of veterinary medicine, where antimicrobial agents are routinely employed, the emergence of resistant pathogens has amplified the need for alternative therapeutic options. Cannabis-derived terpenes, known for their diverse biological activities, are increasingly gaining attention for their antimicrobial properties. Our aim is to explore the potential of cannabis-derived terpenes as a novel avenue to address antimicrobial resistance in veterinary treatments.